RFI for Clinician Advisory Services

The State of Oregon's Department of Consumer and Business Services, Division of Financial Regulation, has issued a Request for Information (RFI) to gather insights and proposals concerning Clinician Advisory Services for the Oregon Prescription Drug Affordability Board. This solicitation, identified by number S-44000-00015479, seeks qualified responses from interested parties to assist the Board in evaluating prescription drug affordability and related clinical expertise. The responses are due by January 30, 2026, following the posting date of December 19, 2025. The work will be based in Salem, Oregon, and is categorized under the NAICS code 441110. Interested respondents can contact the DCBS Stockroom for DFR at the provided phone number or email for further information. This RFI represents an opportunity for clinicians to contribute their advisory knowledge to a state-level effort aimed at improving drug cost management and patient access. The solicitation does not specify any type of set-aside, indicating an open solicitation aimed at gathering information to inform future decision-making by the Board. All details and submission guidelines are accessible through the Oregon Buys platform.